Elevance Health Inc.

NYSE ELV

Elevance Health Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2024: USD 174.01 B

Elevance Health Inc. Revenue is USD 174.01 B for the Trailing 12 Months (TTM) ending September 30, 2024, a 3.20% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Elevance Health Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 168.62 B, a 10.03% change year over year.
Elevance Health Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 153.25 B, a 14.46% change year over year.
Elevance Health Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 133.88 B, a 13.99% change year over year.
Elevance Health Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 117.45 B, a 17.24% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

NYSE: ELV

Elevance Health Inc.

CEO	Ms. Gail Koziara Boudreaux
IPO Date	Oct. 30, 2001
Location	United States
Headquarters	220 Virginia Avenue
Employees	104,900
Sector	Health Care
Industries Telehealth Health Insurance & Plans

Description

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Key trends

Past 5 years